SofiadisA, DinetsA, OrreLM, BrancaRM, JuhlinCC, FoukakisT, WallinG, HoogA, HulchiyM, ZedeniusJ, LarssonC, LehtioJ. 2010. Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca(2+)-binding protein S100A6 in papillary thyroid carcinoma. Thyroid, 20this issue.
2.
De PetrisL, OrreLM, KanterL, PernemalmM, KoyiH, LowensohnR, LehtioJ. 2009. Tumor expression of S100A6 correlates with survival of patients with stage I non-small cell lung cancer. Lung Cancer, 63:410–417.
3.
OrreLM, PernemalmM, LengqvistJ, LewensohnR, LehtioJ. 2007. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Mol Cell Proteomics, 6:2122–2131.
4.
BrownLM, HelmkeSM, HunsuckerSW, Netea-MaierRT, ChiangSA, HeinzDE, ShroyerKR, DuncanMW, HaugenBR. 2006. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog, 45:613–626.
5.
Netea-MaierRT, HunsuckerSW, HoevenaarsBM, HelmkeSM, SlootwegPJ, HermusAR, HaugenBR, DuncanMW. 2008. Discovery and validation of protein abundance differences between follicular thyroid neoplasms. Cancer Res, 68:1572–1580.
6.
ItoY, YoshidaH, TomodaC, UrunoT, MiyaA, KobayashiK, MatsuzukaF, KakudoK, KumaK, MiyauchiA. 2005. Expression of S100A2 and S100A6 in thyroid carcinomas. Histopathology, 46:569–575.
7.
SrisomsapC, SubhasitanontP, OttoA, MuellerEC, PunyaritP, Wittmann-LieboldB, SvastiJ. 2002. Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis. Proteomics, 2:706–712.
8.
ObermaierC, JankowskiV, SchmutzlerC, BauerJ, WildgruberR, InfangerM, KohrleJ, KrauseE, WeberG, GrimmD. 2005. Free-flow isoelectric focusing of proteins remaining in cell fragments following sonication of thyroid carcinoma cells. Electrophoresis, 26:2109–2116.
9.
RussoD, BiscaA, CelanoM, TalamoF, ArturiF, ScipioniA, PrestaI, BulottaS, FerrettiE, FilettiS, ScaloniA, DamanteG, TellG. 2005. Proteomic analysis of human thyroid cell lines reveals reduced nuclear localization of Mn-SOD in poorly differentiated thyroid cancer cells. J Endocrinol Invest, 28:137–144.
10.
ArcinasA, YenTY, KebebewE, MacherBA. 2009. Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns. J Proteome Res, 8:3958–3968.
11.
SalzanoAM, ParonI, PinesA, BachiA, TalamoF, BiviN, VascottoC, DamanteG, QuadrifoglioF, ScaloniA, TellG. 2006. Differential proteomic analysis of nuclear extracts from thyroid cell lines. J Chromatogr B Analyt Technol Biomed Life Sci, 833:41–50.
12.
KrauseK, SchierhornA, SinzA, WissmannJD, Beck-SickingerAG, PaschkeR, FuhrerD. 2006. Toward the application of proteomics to human thyroid tissue. Thyroid, 16:1131–1143.
SurianoR, LinY, AshokBT, SchaeferSD, SchantzSP, GeliebterJ, TiwariRK. 2006. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. J Proteome Res, 5:856–861.
15.
GiustiL, IacconiP, CiregiaF, GiannacciniG, DonatiniGL, BasoloF, MiccoliP, PincheraA, LucacchiniA. 2008. Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res, 7:4079–4088.
16.
SlomnickiLP, NawrotB, LesniakW. 2009. S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol, 41:784–790.
